Amyloid Imaging and Cognitive Impairment After Intracerebral Hemorrhage
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Florbetapir F 18 (Primary)
- Indications Cerebral amyloid angiopathy; Intracranial haemorrhages
- Focus Diagnostic use
- 19 Jul 2017 Results assessing florbetapir retention in cerebral amyloid angiopathy-related hemorrhages (n=33) published in the Neurology
- 21 Feb 2017 Planned End Date changed from 1 Dec 2015 to 1 Jun 2017.
- 21 Feb 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Jun 2017.